Figure 2 4 GLP-1RA reduced the risk of stroke in T2D patients clinically As a new type of hypoglycemic drug, GLP-RAs are currently mainly used in clinical practice to evaluate the prognosis of various complications in T2D patients, such as stroke, kidney injury, fatty liver, and cardiovascular disease (42, 43)
But one should be careful about aspects like sterility and hygiene, and the expertise of the person administering the treatment
Neurology 84 , 22472257 (2015)
J Funct Foods 7:6776 Atwell LL, Hsu A, Wong CP, Stevens JF, Bella D, Yu TW, Dashwood RH (2015) Absorption and chemopreventive targets of sulforaphane in humans following consumption of broccoli sprouts or a myrosinase-treated broccoli sprout extract
For a visible skin effect, glutathione works on a course rather than a one-off